Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blind Procedures02:07

Blind Procedures

10.7K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
10.7K
Blinding01:11

Blinding

2.5K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.5K
Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

6.2K
At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...
6.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mutualism-here, there, and everywhere<b>The Call Of The Honeyguide</b> <i>Rob Dunn</i> Basic Books, 2025. 352 pp.

Science (New York, N.Y.)·2025
Same author

Support US OCTOPUS Act to keep octopuses wild.

Science (New York, N.Y.)·2024
Same author

The US Response to COVID-19 and Climate Change Endangers the Country and the World.

One earth (Cambridge, Mass.)·2021
Same author

Liberating primatology.

Journal of biosciences·2018
Same author

Climate change, responsibility, and justice.

Science and engineering ethics·2009
Same author

Conference covered climate from all angles.

Science (New York, N.Y.)·2009

Related Experiment Video

Updated: Aug 9, 2025

Cell-Free Dot Blot as a Practical and Adaptable Immunoassay Platform for the Detection of Antibody Response in Human and Animal Sera
08:21

Cell-Free Dot Blot as a Practical and Adaptable Immunoassay Platform for the Detection of Antibody Response in Human and Animal Sera

Published on: May 23, 2025

402

Blind spots in biodefense.

Ann Linder1, Dale Jamieson2

  • 1Ann Linder is at the Brooks McCormick Jr. Animal Law and Policy Program, Harvard Law School, Cambridge, MA, USA.

Science (New York, N.Y.)
|February 16, 2023
PubMed
Summary
This summary is machine-generated.

The updated National Biodefense Strategy (NBS-22) overlooks domestic animal-related risks, focusing instead on external threats. This oversight in biodefense planning could have global implications for public health security.

More Related Videos

Safety Precautions and Operating Procedures in an ABSL-4 Laboratory: 4. Medical Imaging Procedures
09:36

Safety Precautions and Operating Procedures in an ABSL-4 Laboratory: 4. Medical Imaging Procedures

Published on: October 3, 2016

11.1K
Safety Precautions and Operating Procedures in an ABSL-4 Laboratory: 1. Biosafety Level 4 Suit Laboratory Suite Entry and Exit Procedures
09:54

Safety Precautions and Operating Procedures in an ABSL-4 Laboratory: 1. Biosafety Level 4 Suit Laboratory Suite Entry and Exit Procedures

Published on: October 3, 2016

36.2K

Related Experiment Videos

Last Updated: Aug 9, 2025

Cell-Free Dot Blot as a Practical and Adaptable Immunoassay Platform for the Detection of Antibody Response in Human and Animal Sera
08:21

Cell-Free Dot Blot as a Practical and Adaptable Immunoassay Platform for the Detection of Antibody Response in Human and Animal Sera

Published on: May 23, 2025

402
Safety Precautions and Operating Procedures in an ABSL-4 Laboratory: 4. Medical Imaging Procedures
09:36

Safety Precautions and Operating Procedures in an ABSL-4 Laboratory: 4. Medical Imaging Procedures

Published on: October 3, 2016

11.1K
Safety Precautions and Operating Procedures in an ABSL-4 Laboratory: 1. Biosafety Level 4 Suit Laboratory Suite Entry and Exit Procedures
09:54

Safety Precautions and Operating Procedures in an ABSL-4 Laboratory: 1. Biosafety Level 4 Suit Laboratory Suite Entry and Exit Procedures

Published on: October 3, 2016

36.2K

Area of Science:

  • Public Health
  • Biosecurity
  • Veterinary Medicine

Background:

  • The Biden administration's National Biodefense Strategy (NBS-22) is the first update since the COVID-19 pandemic.
  • NBS-22 acknowledges global interconnectedness regarding health threats but primarily frames them as external.
  • The strategy prioritizes bioterrorism and laboratory accidents over domestic risks.

Discussion:

  • NBS-22 neglects significant biosecurity threats arising from routine animal agriculture and use within the U.S.
  • While acknowledging zoonotic diseases, the strategy deems existing legal and institutional frameworks sufficient, potentially hindering proactive measures.
  • This narrow focus contrasts with the pandemic's lessons about the pervasive nature of biological threats.

Key Insights:

  • The U.S. National Biodefense Strategy (NBS-22) fails to comprehensively address domestic risks from animal agriculture.
  • Routine practices in animal use and production represent a significant, yet overlooked, biosecurity vulnerability.
  • The strategy's limited scope on zoonotic disease prevention may impede effective global health security.

Outlook:

  • Future biodefense strategies must integrate domestic animal-related risks for a more robust public health framework.
  • Enhanced surveillance and regulation of animal agriculture practices are crucial for mitigating zoonotic disease emergence.
  • International collaboration on biodefense needs to encompass a broader understanding of threat origins, including domestic ones.